close

Fundraisings and IPOs

1 2 3 4 5 77
Number of results: 1532
Date Company Amount Funding type Investors Therapeutic area Type of Information
2018-09-28 KSQ Therapeutics (USA - MA) $80 million series C financing round Flagship Pioneering (USA - MA) Polaris Partners (USA - MA) ARCH Venture Partners (USA - IL) Alexandria Equities (USA - CA) Baillie Gifford (UK) Cowen Healthcare Investments (USA - NY) Invus (USA - NY) Lilly Asia Ventures (China) Cancer - Oncology - Immunological diseases - Rare diseases Series C financing round
2018-09-26 Minoryx Therapeutics (Spain) €21.3 million series B financing round Chiesi Ventures (Italy) Caixa Capital Risc (Spain) HealthEquity (Spain) Fund+ (Belgium) Idinvest Partners (France) Kurma Partners (France) Sambrinvest (Belgium) Kurma Partners (France) Ysios Capital (Spain) SFPI-FPIM, S.R.I.W Rare diseases Series B financing round
2018-09-20 Fate Therapeutics (USA - CA) private placement Cancer - Oncology - Immunological diseases Private placement
2018-09-20 Y-mAbs Therapeutics (USA - NY) IPO Cancer - Oncology IPO
2018-09-12 CODA Biotherapeutics (USA - CA) $19 million series A financing round MPM Capital (USA - MA) Versant Ventures (USA - CA) Astellas Venture Management (USA - CA) Novartis (Switzerland) Neurological diseases - CNS diseases Series A financing round
2018-09-12 Exocobio (Republic of Korea) $27 million series B financing round Seven Tree Equity Partners (Republic of Korea) CSQUARED Global Asset Management (Republic of Korea) TS Investment Partners (Dubai) K2 Investment, Intervest (Republic of Korea) KDB Capital (Republic of Korea) Atinum Investment (Republic of Korea) GU Equity Partners (Republic of Korea) QUANTUM Ventures Korea (Republic of Korea) Platinum technology Investment (Republic of Korea) Autoimmune diseases - Dermatological diseases Series B financing round
2018-09-11 ProQR Therapeutics (The Netherlands) $104.1 million private placement Rare diseases - Genetic diseases - Ophtalmological diseases Private placement
2018-09-07 Oasmia Pharmaceutical (Sweden) SEK 35.2 million private placement Cancer - Oncology Private placement
2018-09-06 Twentyeight-Seven Therapeutics (USA - MA) $65 million series A financing round MPM Capital (USA - MA) Novartis Venture Fund (USA - MA) Johnson & Johnson Innovation – JJDC (USA - NJ) Vertex Ventures (USA - CA) Longwood Fund (USA - MA) Astellas Venture Management (USA - CA) Cancer - Oncology Series A financing round
2018-09-06 Allogene Therapeutics (USA - CA) $120 Million financing round Cancer - Oncology Financing round
2018-09-05 Forendo Pharma (Finland) € 4 million financing round Vesalius Biocapital (Luxembourg) Women health Financing round
2018-09-05 Retrophin (USA - CA) $240 million private placement Rare diseases Private placement
2018-09-05 4D Molecular Therapeutics (USA - CA) $ 90 million series B financing round Viking Global Investors (USA - CT) ArrowMark Partners (USA - CO) Janus Henderson Investors (UK) The Biotechnology Value Fund (USA - CA) MiraeAsset Financial Group (Republic of Korea) Pappas Capital & Chiesi Ventures (USA - NC)  Pfizer Ventures (USA - NY) Perceptive Advisors  (USA - NY) Ridgeback Capital Investments (USA - NY) CureDuchenne Ventures (USA - CA) Berkeley Catalyst Fund (USA - CA) Rare diseases - Genetic diseases Series B financing round
2018-08-31 Antabio (France) € 12.5 million series A financing round iXO Private Equity (France) IRDI SORIDEC Gestion (France) Galia Gestion (France) Omnes Capital (France) BNP Paribas Développement (France) Sham Innovation Santé (Turenne Capital) (France) and company’s historical investors including former President of OM Pharma Christophe Ricard. Rare diseases - Infectious diseases Series A financing round
2018-08-16 Krystal Biotech (USA - PA) $10 million private placement Frazier Healthcare Partners (USA - WA) Rare diseases - Genetic diseases Private placement
2018-08-13 Orchard Therapeutics (UK) $150 Million series C financing round ArrowMark Partners (USA - CO) Cormorant Asset Management (USA - MA) Foresite Capital (USA - NY) RA Capital Management (USA - MA) Perceptive Advisors (USA - NY) RTW Investments (USA - NY) Venrock (USA - CA) Foresite Capital (USA - NY) Sphera Global Healthcare (Spain) Medison Ventures Driehaus Capital Management (USA - IL) Ghost Tree Capital Group (USA - NY) Temasek (Singpore) Baillie Gifford (UK) Cowen Healthcare (USA - NY) Agent Capital (USA - MA) Rare diseases - Genetic diseases Series C financing round
2018-08-09 Bavarian Nordic (Denmark) € 30 million loan European Investment Bank (EIB) Infectious diseases Loan
2018-08-08 Beigene (China) $903 million IPO Cancer - Oncology IPO
2018-08-08 SQZ Biotech (USA - MA) $72 million series C financing round Everblue Management (USA) Illumina Ventures (USA - CA) Invus (USA - NY) Orient Life (AE) Viva Ventures Biotech Group (USA) Bridger Healthcare Partners (USA) Global Health Science Fund (USA)  GV (USA - CA) JDRF T1D Fund, (USA - NY) NanoDimension (USA - CA) Polaris (USA - MA) Cancer - Oncology - Metabolic diseases Series C financing round
2018-08-08 Ambys Medicines (USA - CA) $60 million series A financing round Third Rock Ventures (USA - MA) Takeda Pharmaceutical (Japan) Liver diseases - Hepatic diseases Series A financing round